Europe
Engineered to address the rigorous requirements and complexity of biologics manufacture, Sartorius’ BIOSTAT STR® Generation 3 single-use bioreactor and BIOBRAIN automation platform introduce innovations that will change the field of biopharmaceutical process development and manufacturing.
Numerous organizations are cancelling or postponing activities that involve large groups of people.
Marinomed Biotech AG, a globally active biopharmaceutical company based in Vienna, has achieved promising results for further areas of application with its Marinosolv® technology platform in preclinical studies.
“We are extremely motivated to be working hand-in-hand with these premier institutes, among the leaders in cell-based immunotherapy discovery and development, to exhibit the use of the closed, automated Cocoon® Platform for manufacturing cell therapies.
Grant awarded by the Wellcome Trust and DFID, as part of UK government’s £46 million international COVID-19 prevention and research package
GlobalData, a leading data and analytics company, pegged the 10 drugs to hit sales of $1 billion and more per year.
The research was published in the journal Cancer Research.
Novartis’ Isturisa (osilodrostat) was approved for adults with Cushing’s disease who either can’t have pituitary gland surgery or who have had the surgery but still have the disease.
New study data show that monitoring blood levels of sphingotec’s endothelial function biomarker bio-ADM(R) on top of guideline parameter lactate improves risk stratification of sepsis patients admitted to intensive care units
Although March looks to be a busy month for the U.S. Food and Drug Administration, several of the PDUFA dates for this week were for drugs under Priority Review.
PRESS RELEASES